About this trial

SENIOR transplant Registry European transplant registry of senior renal transplant recipients (above the age of 65 years) receiving initial immunosuppression with tacrolimus once daily, mycophenolate and steroids to investigate long term outcomes on an observational basis.

Eligibility criteria

Qualifiers

Males or females, aged ≥65 years

Patients who received a renal allograft

Patients who are willing and able to participate in the study and from whom written informed consent has been obtained

Patients on an intended standard triple therapy with tacrolimus once daily (Advagraf with trough level ≥5ng/ml) in combination with mycophenolate (either ≥1.0g/day MMF or ≥720mg/d EC-MPS) and Steroids (≥5mg prednisolone or equivalent)

Disqualifiers

Multi-organ recipients (solid organ or bone marrow)

More than secondary renal allograft recipients

Blood group A,B,O-incompatible allografts

Documented presence of donor specific antibodies (DSA)

Trial design

Treatments tested in this trial

  • Tacrolimus once daily (Advagraf)

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators

Klemens Budde

Lead sponsor

Charite University, Berlin, Germany

Sponsor institution

Dr. med. univ. L. J. Lehner

Collaborator

Charite University, Berlin, Germany

Collaborator

ERA-EDTA

Collaborator

DESCARTES Working Group On Transplantation

Collaborator

European Kidney Transplant Association (EKITA)

Collaborator